Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Number of holders
-
126
-
Total 13F shares, excl. options
-
35,744,834
-
Shares change
-
+2,170,037
-
Total reported value, excl. options
-
$715,228,449
-
Value change
-
+$44,754,005
-
Put/Call ratio
-
215%
-
Number of buys
-
79
-
Number of sells
-
-45
-
Price
-
$20.01
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q3 2017
163 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q3 2017.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35,744,834 shares
of 80,437,135 outstanding shares and own 44.44% of the company stock.
Largest 10 shareholders include Consonance Capital Management LP (3,946,009 shares), RTW INVESTMENTS, LP (3,495,143 shares), BlackRock Inc. (3,142,776 shares), VANGUARD GROUP INC (2,935,293 shares), D. E. Shaw & Co., Inc. (2,362,968 shares), STATE STREET CORP (1,755,186 shares), Boxer Capital, LLC (1,250,000 shares), SCOPIA CAPITAL MANAGEMENT LP (1,194,129 shares), FMR LLC (1,158,154 shares), and WELLINGTON MANAGEMENT GROUP LLP (1,149,037 shares).
This table shows the top 126 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.